Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 04-2013 | 01-2013 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 90 | 529 |
| Marketable Securities | 5,187 | 5,551 |
| Receivables | 157 | 10 |
| TOTAL | $5,585 | $6,189 |
| Non-Current Assets | ||
| PPE Net | 6 | 5 |
| Intangibles | 1,385 | 1,579 |
| TOTAL | $1,391 | $1,584 |
| Total Assets | $6,975 | $7,773 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 181 | 145 |
| TOTAL | $181 | $145 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $181 | $145 |
| Shareholders' Equity | ||
| Common Shares | 25,875 | 24,935 |
| Retained earnings | -22,742 | -22,734 |
| Other shareholders' equity | 914 | 2,647 |
| TOTAL | $6,794 | $7,629 |
| Total Liabilities And Equity | $6,975 | $7,773 |